Singapore has one of the lowest fertility rates in the world, and as more women enter the workforce, the number of births has declined and the childbearing population has aged.

And although the Asian femtech market is still underdeveloped and many companies are reluctant to enter due to cultural, linguistic, and institutional differences, fermata - one of the kegg's investors, is very optimistic when it comes to the future of this new emerging market in Asia.

"Our aim is that, through our platform, we can provide a range of services for femtech companies to approach the Japanese and Asian markets, primarily pioneering companies who share our vision of transforming the taboos women face into an exciting culture of self-care. Despite the growing number of potential startups in this field, I think there is still some level of hesitation observed among the investors. Mainly because female wellness and sexual wellness are still being considered as a big taboo in Japan," Amina Sugimoto, co-founder and CEO of fermata, shares with me in an email.

"The daily habit of knowing and predicting our unique cyclical rhythms can empower women at every stage of their lives to live with less stress and more confidence, which is precisely why we decided to invest in kegg, one of the best tools for self-monitoring of a woman's hormonal cycle we've seen out there. Following the global femtech trends, we expect to bring in more data-driven products which serve in your menstrual cycle, pregnancy, and menopause in near future at fermata Singapore's marketplace. Therefore, we make sure that every company we choose to partner with are creating products that are effective, safe, and most importantly, fun to use," Naomi Tanno, Country Manager for fermata Singapore, ads.

Click HERE to read the full article